1. Two main groups of drugs that are important in the treatment of Parkinson’s:
2. In what way does Amantadine act as an antiparkinsonism drug:
Amantadine increases DA neurotransmission by increasing the synthesis or release of dopamine ot the inhibition of DA reuptake. It also blocks muscarinic action.
3. MOA of antiparkinsonism drugs that increases DA concentration indicectly:
4. Which drugs are ergot derivatives and which are not:
Ergot derivatives:
Non-ergot derivatives:
5. Dopamine receptors stimulated by each agonist:
6. Drugs classified as neuron protecting drugs and what that means:
Neuroprotective drugs are those which protects the brain from being damaged. These drugs include all MAO-B inhibitors and Pramipexole.
7. Importance of MAO-B inhibitors in the treatment of Parkinson’s:
It increases the DA concentration in the CNS. It can be given as a combination therapy with L-dopa. Safinamide also increases DA activity by inhibiting DA reuptake and decreases glutamate release.
8. How do COMT inhibitors act in Parkinsonism:
COMT metabolizes L-dopa to 3-OMD. A COMT inhibitor therefore extends the duration of action of L-dopa, it decreases peripheral metabolism and improves the bio availability.
9. How does Istradephyllin work:
It is an Adenosine A2A antagonist. It can be used as an add-on therapy drug to L-dopa/Carbidopa when experiencing off-episodes.
10. Discuss the MOA of Safinamide:
Safinamide has a novel dual mechanism of action. It increases DA activity by inhibiting MAO-B as well as the inhibition of DA reuptake. The second MOA is that Safinamide decreases glutamate release.
b) Touch, pressure and motor fibres are influenced by a-type fibres. These fibres are the final fibres that are blocked and therefore they are not sensitive to LA.
Compile a table, listing the major effects on every system (cardiovascular, CNS, renal, hepatic and uterus) for all the inhalation anaesthetics. This table is important when it comes to the selection of drugs in certain individuals:
Drug: |
System: |
Effect: |
Halothane |
Central Nervous System |
Fast smooth induction, stadium II absent |
↑ cerebral blood flow and ↑ intracranial pressure |
||
Autonomic |
Bradycardia |
|
CVS |
↓ BP, sensitized myocardium for arythmogenic effects of catecholamines |
|
Respiratory system |
No saliva, bronchial secretions or cough |
|
Musculo-skeletal |
Skeletal muscle relaxing effects stadium III, ↑ action non-depol, ↓ action depol., Post-operative shaking → hypoxia |
|
Uterus |
↓ muscle contractions, → external twisting of baby |
|
Liver |
Hepatotoxic (rare, unpredictable) |
|
Status |
Not often used because of hepatotoxicity + newer drugs |
|
Enflurane |
CNS |
Fast, smooth induction convulsions sometimes, NOT epileptics |
CVS |
No sensitization of the myocardium, less ↓ than Halothane |
|
Respiratory |
More↓ than Halothane |
|
Status |
Not often used. Maintenance |
|
Isoflurane |
CNS |
Faster induction + recovery than Halothane |
CVS |
Less ↓ than Halothane + Enflurane No sensitization of myocardium |
|
Respiratory |
Potent ↓ effect. Strengthens because of potent skeletal muscle relaxing effect |
|
Status |
More ideal drug than Halothane and Enflurane. Widely used. Has replaced Halothane and enflurane. Not for patients who have to breath spontaneously. |
|
Desflurane |
CNS |
Even faster induction + recovery than Isoflurane, ↑ cerebral blood flow and intracranial pressure |
CVS |
Less ↓ than Halothane + Enflurane |
|
Respiratory |
Strong smell, irritate airways, if used as induction drug → cough, shortness of breath and laringospasm |
|
Status |
Even more ideal than Isoflurane or sevoflurane. Potential to be used for various surgical procedures. Because of effect on resp → NOT as induction |
|
Sevoflurane |
CNS |
Potentiate the effects of the non-depolarising muscle relaxants like the other halogenated ethers |
Respiratory |
Effects similar to Desflurane, less irritation of airways |
|
Status |
Induction and maintenance |
|
Nitrous Oxide |
CNS |
Weak anesthetic, potent analgesic, amnesia |
CVS |
No effect |
|
Respiratory |
Pure N2O → hypoxia, always mix with O2 or air. Recovery phase: N2O fast diffusion from blood to alveoli, ↓ O2 pressure, → hypoxia |
|
Status |
As additive drug in anesthesia Single drug for short dental procedures e.g. extractions |
Name the major acute toxic effects of the inhalation drugs:
Reference list:
Brand, L.Prof. 2021. Study Unit 5: General Anaesthesia. Unpublished lecture notes on efundi, FKLG 312. Potchefstroom: NWU. [PowerPoint presentation].
Botanical substances or natural substances are plant based medicines that don't have to go through the rigorous testing that registered medicines do. These substances are therefore dangerous to use without the input of a pharmacist or a doctor as they can still have adverse effects on a patient as well as have a contra-indication or a bad interaction with medicines that are already being used by the patient. These medicines might be considered 'safer' due to the fact that it is a natural product but it is more dangerous because of the information we do not have.
Botanical substances for use as anxiolytics: Lavender, Valerian, Passion flower, Lemon balm, Linden, Chamomile.
Botanical substances for uses as hypnotics: Passion flower, Jamaican dogwood, Skullcap, Motherwort, Hops, Californian poppy.
1. Absorption and distribution of drugs are affected the most by lipid solubility. Lipid solubility helps sedative-hypnotic drugs to be absorbed into the central nervous system. This factor is responsible for how fast the sedative-hypnotic drugs start working. The clinical significance of this is that the more lipophilic a drug is, the faster and better it is absorbed into the patients system.
2. Redistribution of drugs is when a lipid soluble drug is distributed to the organs of the body and is then distributed again into the fat and tissue. Redistribution is done to lengthen the action of the drug.
3. The metabolism of BDs happen via biotransformation by hepatic enzymes and in 3 steps:
4. The benzodiazepines that are converted to active metabolites are:
By converting BDs to active metabolites, you lengthen the duration of action of the drug.
5. The BDs that are not dependent on the cytochrome P450 oxidative enzymes are:
These drugs are not metabolised by the CYP450 enzymes. It is therefore the preferred drug for patients with decreased CYP450 enzyme activity.
6. Enzyme induction is when a drug causes an increase in the production of specific enzymes that betters the metabolism of that drug. A drug that causes this include: phenobarbital. Enzyme induction decreases the amount of drugs in the patient's circulation which causes the therapeutic effect to be decreased.
1. Anterograde amnesia and drugs that can cause this?
Anterograde amnesia or proactive amnesia is a subset of amnesia where the patient struggles to make new memories from new experiences and information. This is caused by Adco-alzam, Ativan, Azor, Brazepam, Bromaze, CPL Alliance Alprazolam, Demetrin, Lexotan.
2. Benzodiazepines (BD) helps patients to fall asleep faster, which lengthens the time that a patient can sleep. BDs in high dosages decreases REM sleep. These drugs are significant to the patient as it helps with sleeplessness and insomnia. They help a patient sleep longer.
3.
Sedative-hypnotic drugs put patients to sleep and can therefore be used as anaesthesia. Anaesthesia helps the patient because an operation can be traumatic.
4.
5. The mechanism of action of the carbamates and the BDs are that they inhibit multiple synaptic reflexes.
6. Sedative-hypnotic drugs decreases the cardiovascular and respiratory systems. They therefore decrease respiratory and cardiovascular disease.
1. Voltage-gated and Ligand-gated ion channels
2. Voltage-gated ion channels respond to changes in the membrane potential of a cell, it transmits a signal to the nerve terminal and it includes Ca2+, K+ and Na+ ion channels whereas ligand-gated channels work by binding the ligand neurotransmitter (NT) to the ion channel, is an ionotropic receptor and can be found both presynaptic and postsynaptic.
3. Ionotropic receptors bind directly to the receptor and opens the ion channels. Metabotropic receptors on the other hand doesn't bind directly to the receptor but is a G-protein-coupled receptor that releases secondary messengers thus opening the ion channels.
4. Ionotropic receptors include: GABAA, Nicotinic, EAA and 5-HT3 receptors.
Metabotropic receptors work with 2 transduction systems, these are: Adenylyl cyclase systems and Phospholipase C systems.
In the Adenylyl Cyclase System, the receptors are positively and negatively bound. The positively bound receptors include: β1+2 and D1. These receptors stimulates the formation of secondary messengers. The negatively bound receptors, on the other hand, includes: D2, α2, 5-HT1A+B and M2. These receptors suppresses the formation of cAMP.
In the Phospholipase C system, the receptors are only positively bound. These receptors include: α1, 5-HT2, M1, H1.
5. EPSP is generated by the opening of Na+ or Ca2+ channels whereas IPSP is generated by opening of K+ or Cl-.
6. Calcium causes a change in the action potential of the presynaptic membrane which in turn releases the neurotransmitters needed to cause an effect in the postsynaptic membrane. Thus, calcium is an essential part of producing a synaptic potential.